FZD10 and neoplasm: When it was radiolabeled with Yttrium-90 (90Y), a highly energetic beta emitter radioisotope, tumor shrinkage was observed in immunocompromised Balb-c mice bearing established FZD10-positive SS tumor subcutaneous xenografts (SYO-1 cell line), without significant toxicity [10].